questionsmedicales.fr
Facteurs biologiques
Pigments biologiques
Porphyrines
Uroporphyrines
Uroporphyrines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Uroporphyrines
Analyse d'urine
Électrophorèse
Uroporphyrines
Tests génétiques
Uroporphyries
Historique médical
Facteurs de risque
Symptômes
5
Problèmes cutanés
Uroporphyrines
Symptômes psychologiques
Uroporphyrines
Douleurs abdominales
Uroporphyrines
Variabilité des symptômes
Uroporphyrines
Prévention
5
Prévention
Uroporphyrines
Alimentation
Uroporphyrines
Examens réguliers
Uroporphyrines
Vaccinations
Uroporphyrines
Traitements
5
Traitements
Uroporphyrines
Transfusions sanguines
Uroporphyrines
Photothérapie
Uroporphyrines
Médicaments
Uroporphyrines
Traitements alternatifs
Uroporphyrines
Complications
5
Complications
Uroporphyrines
Troubles hépatiques
Uroporphyrines
Qualité de vie
Uroporphyrines
Complications réversibles
Uroporphyrines
Complications psychologiques
Uroporphyrines
Facteurs de risque
5
Facteurs de risque
Uroporphyrines
Alcoolisme
Uroporphyrines
Médicaments
Facteurs de risque
Infections
Uroporphyrines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Uroporphyrines : Questions médicales les plus fréquentes",
"headline": "Uroporphyrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Uroporphyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-01",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Uroporphyrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Porphyrines",
"url": "https://questionsmedicales.fr/mesh/D011166",
"about": {
"@type": "MedicalCondition",
"name": "Porphyrines",
"code": {
"@type": "MedicalCode",
"code": "D011166",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Uroporphyrines",
"alternateName": "Uroporphyrins",
"code": {
"@type": "MedicalCode",
"code": "D014578",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Juliana Bragazzi Cunha",
"url": "https://questionsmedicales.fr/author/Juliana%20Bragazzi%20Cunha",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA. bragazzi@umich.edu."
}
},
{
"@type": "Person",
"name": "Jared S Elenbaas",
"url": "https://questionsmedicales.fr/author/Jared%20S%20Elenbaas",
"affiliation": {
"@type": "Organization",
"name": "Medical Scientist Training Program, Washington University, Saint Louis, 63110, USA."
}
},
{
"@type": "Person",
"name": "Dhiman Maitra",
"url": "https://questionsmedicales.fr/author/Dhiman%20Maitra",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
},
{
"@type": "Person",
"name": "Ning Kuo",
"url": "https://questionsmedicales.fr/author/Ning%20Kuo",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
},
{
"@type": "Person",
"name": "Rodrigo Azuero-Dajud",
"url": "https://questionsmedicales.fr/author/Rodrigo%20Azuero-Dajud",
"affiliation": {
"@type": "Organization",
"name": "Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Osteosarcoma.",
"datePublished": "2022-12-08",
"url": "https://questionsmedicales.fr/article/36481668",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41572-022-00409-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advances in Osteosarcoma.",
"datePublished": "2023-06-17",
"url": "https://questionsmedicales.fr/article/37329384",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11914-023-00803-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group.",
"datePublished": "2023-03-17",
"url": "https://questionsmedicales.fr/article/36928868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cncr.34744"
}
},
{
"@type": "ScholarlyArticle",
"name": "Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group.",
"datePublished": "2023-02-25",
"url": "https://questionsmedicales.fr/article/36842425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jgo.2023.101445"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality.",
"datePublished": "2022-10-13",
"url": "https://questionsmedicales.fr/article/36311748",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.871076"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pigments biologiques",
"item": "https://questionsmedicales.fr/mesh/D010860"
},
{
"@type": "ListItem",
"position": 4,
"name": "Porphyrines",
"item": "https://questionsmedicales.fr/mesh/D011166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Uroporphyrines",
"item": "https://questionsmedicales.fr/mesh/D014578"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Uroporphyrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Uroporphyrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Uroporphyrines",
"description": "Comment diagnostiquer une accumulation d'uroporphyrines ?\nQuels tests sont utilisés pour évaluer les uroporphyrines ?\nQuels symptômes peuvent indiquer un excès d'uroporphyrines ?\nLes tests génétiques sont-ils nécessaires pour le diagnostic ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Osteosarcoma#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Uroporphyrines",
"description": "Quels sont les symptômes courants des troubles liés aux uroporphyrines ?\nLes uroporphyrines provoquent-elles des problèmes cutanés ?\nY a-t-il des symptômes psychologiques associés ?\nLes douleurs abdominales sont-elles fréquentes ?\nComment les symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Osteosarcoma#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Uroporphyrines",
"description": "Comment prévenir les troubles liés aux uroporphyrines ?\nUne alimentation spécifique peut-elle aider ?\nLes examens réguliers sont-ils nécessaires ?\nLe stress influence-t-il les troubles des uroporphyrines ?\nLes vaccinations sont-elles importantes pour ces patients ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Osteosarcoma#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Uroporphyrines",
"description": "Quels traitements sont disponibles pour les troubles des uroporphyrines ?\nLes transfusions sanguines sont-elles une option de traitement ?\nLa photothérapie est-elle efficace pour ces troubles ?\nLes médicaments peuvent-ils réduire les niveaux d'uroporphyrines ?\nY a-t-il des traitements alternatifs recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Osteosarcoma#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Uroporphyrines",
"description": "Quelles complications peuvent survenir avec les uroporphyrines ?\nLes troubles hépatiques sont-ils une complication possible ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications psychologiques sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Osteosarcoma#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Uroporphyrines",
"description": "Quels sont les principaux facteurs de risque des troubles des uroporphyrines ?\nL'alcoolisme est-il un facteur de risque ?\nLes médicaments peuvent-ils augmenter le risque ?\nLes infections sont-elles un facteur de risque ?\nLe sexe influence-t-il le risque de troubles ?",
"url": "https://questionsmedicales.fr/mesh/D014578?mesh_terms=Osteosarcoma#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une accumulation d'uroporphyrines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par analyse d'urine pour mesurer les niveaux d'uroporphyrines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les uroporphyrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire, comme l'électrophorèse, sont utilisés pour évaluer les uroporphyrines."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un excès d'uroporphyrines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales et des troubles cutanés peuvent indiquer un excès."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent être nécessaires pour confirmer des troubles héréditaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des facteurs de risque et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles liés aux uroporphyrines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, photosensibilité et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les uroporphyrines provoquent-elles des problèmes cutanés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent causer des éruptions cutanées et une sensibilité accrue au soleil."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'anxiété et la dépression peuvent être associés à ces troubles."
}
},
{
"@type": "Question",
"name": "Les douleurs abdominales sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs abdominales sont un symptôme fréquent des troubles des uroporphyrines."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction de la gravité et du type de trouble métabolique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux uroporphyrines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs comme l'alcool et certains médicaments peut aider à prévenir les crises."
}
},
{
"@type": "Question",
"name": "Une alimentation spécifique peut-elle aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en glucides et faible en graisses peut aider à prévenir les symptômes."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à surveiller les niveaux d'uroporphyrines et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les troubles des uroporphyrines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes et déclencher des crises chez certains patients."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes pour ces patients ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent prévenir des infections qui pourraient aggraver l'état de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles des uroporphyrines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des modifications diététiques et des médicaments pour gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les transfusions peuvent être utilisées dans certains cas pour traiter les complications."
}
},
{
"@type": "Question",
"name": "La photothérapie est-elle efficace pour ces troubles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La photothérapie peut aider à réduire les symptômes cutanés liés à la photosensibilité."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils réduire les niveaux d'uroporphyrines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aider à réduire les niveaux d'uroporphyrines dans le corps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme l'acupuncture peuvent être envisagés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les uroporphyrines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions cutanées, des douleurs chroniques et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles hépatiques sont-ils une complication possible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles hépatiques peuvent survenir en raison de l'accumulation d'uroporphyrines."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en provoquant douleur et incapacité fonctionnelle."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme l'anxiété peuvent survenir en raison de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque des troubles des uroporphyrines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies hépatiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'alcoolisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'alcoolisme peut aggraver les symptômes et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils augmenter le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent déclencher des crises chez les personnes sensibles."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de troubles ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles des uroporphyrines sont plus fréquents chez les femmes que chez les hommes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/03/2025
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA. bragazzi@umich.edu.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Medical Scientist Training Program, Washington University, Saint Louis, 63110, USA.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, 48109, USA.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, 48109, USA.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, 48109, USA.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, 48109, USA.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, 08854, USA. bo163@cabm.rutgers.edu.
Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, 48109, USA. bo163@cabm.rutgers.edu.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Cell Regulation, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Division of Digestive Surgery, Department of Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Cell Regulation, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Cell Regulation, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Institute of Post-LED Photonics, Tokushima University, Tokushima 770-8506, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Cell Regulation, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Faculty of Science and Engineering, Saga University, Saga 840-8502, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Division of Digestive Surgery, Department of Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Division of Digestive Surgery, Department of Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Division of Digestive Surgery, Department of Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Division of Digestive Surgery, Department of Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Division of Digestive Surgery, Department of Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Publications dans "Uroporphyrines" :
1 publication dans cette catégorie
Affiliations :
Division of Digestive Surgery, Department of Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Publications dans "Uroporphyrines" :
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in males. The key pathophysiolog...
This article gives a brief overview of the most recent developments in osteosarcoma treatment, including targeting of signaling pathways, immune checkpoint inhibitors, drug delivery strategies as sing...
Osteosarcoma is one of the most common primary malignant bone tumors in children and young adults, with a high risk of bone and lung metastases and a 5-year survival rate around 70% in the absence of ...
Primary rib osteosarcoma has not been investigated extensively, and clinical characteristics and optimal therapeutic strategies have not been defined. The authors used the database of the Cooperative ...
The COSS database was searched for treatment-naive, high-grade osteosarcomas of the rib. Affected patients were analyzed for demographic and tumor-related factors, treatments, and outcomes....
A total of 44 patients (23 males, 21 females; median age, 23 years [range, 6-59]) were identified. Primary metastases were detected in six of 44 (14%) patients. Surgery was performed in 40 of 44 (91%)...
This large series provides evidence that patients with costal primaries are older than the average osteosarcoma patient, but appear to share the similar tumor biology and-if treated according to stand...
Osteosarcoma is typically a disease of the young, but may affect any age. Little is known about the disease in older patients beyond retirement age. We aim to describe the characteristics, treatment, ...
The database of the Cooperative Osteosarcoma Study Group (COSS) was searched for osteosarcoma patients diagnosed from 1980 to 2020 who were aged 65 years or older at diagnosis. Affected individuals we...
Fifty-five eligible patients were detected (median age 68 [range: 65-84] years; male:female = 25:30). Among these patients, 15/55 (27%) tumors were secondary malignancies, 41/55 (75%) were high-grade ...
Osteosarcomas can occur in older individuals. It is more often secondary, axially located, or extraosseous than in younger patients. However, the same treatment principles seem to apply, and selected ...
Osteosarcoma (OS) is one of the most common primary malignant tumors originating in bones. Its high malignancy typically manifests in lung metastasis leading to high mortality. Although remarkable adv...
Chondroblastoma-like osteosarcoma (CBLOS) is a rare and poorly understood variant of OS. We examined the clinicopathological, immunohistochemical and molecular features of six CBLOSs to highlight the ...
We performed histone 3.3 mutation analysis by gene sequencing and/or immunohistochemistry in all cases, while whole exome sequencing (WES) was performed on two CB-like osteosarcomas and 11 conventiona...
CBLOSs were predominantly localised at acral sites and involved mainly male subjects with a mean age of 29 years. One patient who had metastases at presentation died of disease, while another patient ...
CBLOS presents a different genetic background and a less aggressive clinical behaviour in comparison with CHGOS. Search of the H3F3B K36M mutation is useful in the differential diagnosis with CB....
Primary osteosarcomas are rarely seen in areas other than bone, although they can occur in sites such as the thigh, anal region, hand, etc. We present a case of primary extraskeletal osteosarcoma of t...
Osteosarcoma (OS) is the most prevalent and fatal type of bone tumor. It is characterized by great heterogeneity of genomic aberrations, mutated genes, and cell types contribution, making therapy and ...
Osteosarcoma has become the most common bone malignancy in adolescents. Although the clinical treatment of osteosarcoma has advanced considerably in recent years, the 5-year survival rate has not impr...
We selected prognostic genes that are closely associated with osteosarcoma clinical features by obtaining osteosarcoma patient information from the GTEx and TARGET databases, and then we developed a r...
In conclusion, we validated that the prognostic factor FKBP11 is closely associated with osteosarcoma. Additionally, we identified a novel mechanism by which FKBP11 ameliorates the malignant propertie...
There is no clear consensus guideline that specifies the optimum course of treatment for adult head and neck osteosarcoma (HNO) because of its rarity. The review's goal is to examine the most recent r...
Due to overlapping symptoms with various benign disorders of the lower jaw and midface bone, these patients present with a noticeable delay. The greatest results for these malignancies can be achieved...
Multimodality treatments seem to yield better results for advanced HNO with adverse features and incomplete resections....